X Fintech Innov Stock Quote XFSN - Stock Price, News, Charts, Message Board, Trades

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
ETFs
UK
LSE
X Fintech Innov (XFSN) Quote

X Fintech Innov (XFSN)

29.9175

0.475

(1.61%)

Closed August 07 11:30AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

29.9175

Bid

29.87

Ask

29.965

Volume

2

29.78 Day's Range 30.0525

0.00 52 Week Range 0.00

Previous Close

29.4425

Open

29.905

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

£ 60

VWAP

29.975

Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2024 and Host Quarterly Conference Call and Webcast

ISELIN, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that has achieved regulatory approval in the EU and UK for the first...

Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024

Company to participate in a fireside chat on Monday, August 5th at 8:00 AM ET ISELIN, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical...

Form 8-K - Current report

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) in the EU for the treatment of wet AMDInitial commercial launches of...

Form PRE 14A - Other preliminary proxy statements

Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference

Live video webcast on Tuesday, June 18th at 12:00 PM ET ISELIN, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the...

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

LYTENAVA™ (bevacizumab gamma) becomes first ophthalmic formulation of bevacizumab to receive European Commission Marketing Authorization for the treatment of wet AMDEuropean Commission decision...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA™ (bevacizumab gamma)United Kingdom (UK) Marketing...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RRRichtech Robotics Inc	$ 0.6184 (67.14%)	188.04M
GTHXG1 Therapeutics Inc	$ 7.065 (66.24%)	34.82M
GNLNGreenlane Holdings Inc	$ 4.05 (56.37%)	1.2M
PETQPetIQ Inc	$ 30.41 (47.84%)	15.96M
SWIMLatham Group Inc	$ 4.40 (41.48%)	12.25M
XPONExpion360 Inc	$ 0.0828 (-68.19%)	96.55M
VBIVVBI Vaccines Inc	$ 0.065 (-51.09%)	29.85M
TLISTalis Biomedical Corporation	$ 4.55 (-49.33%)	316.1k
DZSIDZS Inc	$ 0.5288 (-49.15%)	2.35M
LAZRLuminar Technologies Inc	$ 0.8801 (-37.36%)	62.37M
NVDANVIDIA Corporation	$ 98.91 (-5.12%)	410.39M
SQQQProShares UltraPro Short QQQ	$ 10.83 (3.24%)	257.52M
RRRichtech Robotics Inc	$ 0.6184 (67.14%)	188.04M
PRSTPresto Technologies Inc	$ 0.01975 (-36.29%)	110.71M
ADTXAditxt Inc	$ 1.26 (26.38%)	105.88M

Kool Aid Man

Kool Aid Man 5 minutes ago

Q1 reportedI(Page 1) "Change in Control
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes : ? "
(see "Change in Control” shall mean any events resulting in" definitions at the bottom of page 1)

(Page

tredenwater2

tredenwater2 5 minutes ago

Trader, the stock market is like sitting down in a poker tournament where “groups” of players are all connected with different “teams”. Not to mention the teams (AI) that are studying your “history”. As if it couldnt get any worse the dealers (MM’s) are also on the take as well.

Any

zooey

zooey 6 minutes ago

Supposedly, come on bro..

SloGin

SloGin 6 minutes ago

Again... read the Otc filings

Ex mngmt paid $0.00 for Liberia. They were to invest $500k for the rights. .... Then Qatar opportunity came and they sold preferred shares

Now its new management saying ok give us 30 to 45 days to evaluate Liberia if it fits with the Aust

crazy horse 0

crazy horse 0 6 minutes ago

Miami Fl

https://www.youtube.com/watch?v=4opSw2bqY54&t=1s

Maxthedog

Maxthedog 6 minutes ago

I sent an email asking about MIKAH

What did your e-mail exactly say ?

alidare

alidare 6 minutes ago

Now it looks like you are taking to yourself

Check the numbers sequence, is it something I said?

Jimmy Joe

Jimmy Joe 6 minutes ago

Mighty X $TPTW isn't on NASDAQ yet~? I thought $TPTW would be there lickity-split.
Hey, don't get me wrong I'd take 1, 2, or 3 cents thinking it will be enough to get there.

Mighty X, hope your delusions come true.

How about Alfred from St Lucia~? Took the Gold.

slops

slops 6 minutes ago

Why so negative? News has been on Thurs many times

bbotcs

bbotcs 7 minutes ago

lj: NVDA
$39,300 to buy in the call. Now the term "opportunity cost" is starting to come into the picture.
What if I were to put even half of $39K into SMCI. Maybe put the other half into MSTR, more share of NVDA, etc.

Jack_Herer

Jack_Herer 7 minutes ago

Listed as expired and doesnt show on the map.
Likely couldn't pay the latest annual rental fee and the claims were not renewed for another 3 year term.

jammy32

jammy32 8 minutes ago

I sent an email asking about MIKAH. I encourage all of you to so.

We need more transparency in my opinion.

What I really want to know who will decide the worth of the deal if there ever is one

ChannelTrader

ChannelTrader 8 minutes ago

That's a big deal, and no tax on tips.
TRUMP-No Tax on Social Security!

delerious1

delerious1 8 minutes ago

I would love to have a conversation but Admin is removing my posts from the VIP board and even 1 from here LMFAO

SloGin

SloGin 8 minutes ago

Refute & argue with yourself all you want!

The PR is self explanatory.

They are not saying yes or no to Liberia 30 to 45 days. Their focus is Australia

cashclan

cashclan 9 minutes ago

By DNC

Deligates for Biden might be backing out...

MSM running fake polls in a effort to get through the DNC...

Switch coming is the hot topic

blackcat

blackcat 10 minutes ago

Yes they should!

CaptainObvious

CaptainObvious 10 minutes ago

I always thought that going to the expense of scaling up for a drug that may not even be approved made no sense, and that scaling up would be a requirement for actual approval, was just a canard.

SSKILLZ1

SSKILLZ1 10 minutes ago

I mean clearly to be fair to them yesterday can be explained how many times can you say as a baseball team. Your in LA, go to st louis, and than go to colorado, with no days off between from sunday to tuesday. Obviously that is rough, especially the 3rd day of that. Having said that it doesn't excus

getmoreshares

getmoreshares 10 minutes ago

AGREE-- posted Ga. fraud info from 2020 earlier today

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174881671

fuente

fuente 11 minutes ago

How should I know? It sounds exciting, though!

delerious1

delerious1 11 minutes ago

I have a quote from one....from another board....
"Generally speaking, all companies on the scam OTC are crap….
99% of the time, the pumping posters on IHUB ARE SCAMMERS.…
THAT’S why most truth tellers roam IHUB…….to expose scam, clown pumpers."

chrismiss_everyday

chrismiss_everyday 11 minutes ago

Looking forward to the time that Blarcamesine is amongst the selected medicines…

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-july-2024

sortagreen

sortagreen 11 minutes ago

https://scontent-bos5-1.xx.fbcdn.net/v/t39.30808-6/454633209_8429242483760920_7355887007895644016_n.jpg?stp=dst-jpg_s600x600&_nc_cat=107&ccb=1-7&_nc_sid=127cfc&_nc_ohc=Ve33RosgdYQQ7kNvgEDrRyA&_nc_ht=scontent-bos5-1.xx&oh=00_AYCRaEChTXx_l8wEpyVoS23lWyPrZ_JgQ8l0i0TwLoRTAw&oe=66B9D7AB

X Fintech Innov

Delayed Upgrade Clock